Hypertension, cognitive decline, and dementia: an epidemiological perspective
暂无分享,去创建一个
[1] M Prencipe,et al. Stroke, disability, and dementia: results of a population survey. , 1997, Stroke.
[2] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[3] E. Shimosegawa,et al. Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging. , 1997, Stroke.
[4] W. O'Fallon,et al. Dementia after ischemic stroke , 1996, Neurology.
[5] A. Hofman,et al. Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.
[6] K. Jellinger. Parkinsonism due to binswanger's subcortical arteriosclerotic encephalopathy , 1996, Movement disorders : official journal of the Movement Disorder Society.
[7] A. Hofman,et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.
[8] M. Mindach. Low cerebral blood flow velocity and risk of white matter hyperintensities , 2001, Annals of Neurology.
[9] T. Bekinschtein,et al. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[10] L. Beckett,et al. Current and remote blood pressure and cognitive decline. , 1999, JAMA.
[11] J. Tuomilehto,et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.
[12] Robert Barber,et al. A neuropathological study of periventricular white matter hyperintensities in major depression. , 2003, Journal of affective disorders.
[13] R. Havlik,et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.
[14] J Tuomilehto,et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.
[15] D. Briley,et al. Older people with impaired mobility have specific loci of periventricular abnormality on MRI. , 2002, Neurology.
[16] J. V. van Swieten,et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline , 1991, Annals of neurology.
[17] D. Leys,et al. Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. , 1997, Stroke.
[18] L R White,et al. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. , 1990, Journal of clinical epidemiology.
[19] Frederik Barkhof,et al. White matter lesions and hippocampal atrophy in Alzheimer’s disease , 2004, Neurology.
[20] H Lechner,et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. , 1988, Stroke.
[21] G C Roman,et al. Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.
[22] M. Kaste,et al. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. , 1997, Stroke.
[23] A. Hofman,et al. The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization , 2004, Journal of hypertension.
[24] J. Jolles,et al. Can the blood pressure predict cognitive task performance in a healthy population sample? , 1997, Journal of hypertension.
[25] Kazuomi Kario,et al. Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives: A Prospective Study , 2003, Circulation.
[26] C. Mathers,et al. Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.
[27] H. Yamanouchi,et al. Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. , 1997, Stroke.
[28] J. Staessen,et al. Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects. , 2004, American journal of hypertension.
[29] Neil Chapman,et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. , 2003, Archives of internal medicine.
[30] M. O’Sullivan,et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis , 2002, Neurology.
[31] J. Trojanowski,et al. Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. , 1988, AJR. American journal of roentgenology.
[32] Philip Scheltens,et al. Midlife Blood Pressure and the Risk of Hippocampal Atrophy: The Honolulu Asia Aging Study , 2004, Hypertension.
[33] D. Leys,et al. Poststroke dementia , 2001, Neurology.
[34] G. Baron,et al. Leukoaraiosis and mobility decline: a high resolution magnetic resonance imaging study in older people with mild cognitive impairment , 2004, Neuroscience Letters.
[35] K Yaffe,et al. Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.
[36] E. Corder,et al. Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study. , 2000, Stroke.
[37] R. Baloh,et al. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction , 2001, Neurology.
[38] J. Garcìa,et al. Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.
[39] J F Toole,et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. , 1996, Stroke.
[40] D. Bennett,et al. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. , 2001, Archives of neurology.
[41] B. Cesana,et al. Dementia after first stroke. , 1996, Stroke.
[42] James R. MacFall,et al. Localization of age-associated white matter hyperintensities in late-life depression , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[43] Jan A Staessen,et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002, Archives of internal medicine.
[44] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.
[45] A Hofman,et al. Hypertension and cerebral white matter lesions in a prospective cohort study. , 2002, Brain : a journal of neurology.
[46] A. Hofman,et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study , 1994, Neurology.
[47] E P Steinberg,et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. , 1994, Stroke.
[48] L. Ferrucci,et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. , 2001, American journal of epidemiology.
[49] L. Fried,et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.
[50] L. Hebert,et al. Relation of blood pressure to cognitive function in the elderly. , 1991, American journal of epidemiology.
[51] Y. Stern,et al. Frequency and clinical determinants of dementia after ischemic stroke , 2000, Neurology.
[52] F. Fazekas,et al. Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study , 1997, Journal of the Neurological Sciences.
[53] B. Tress,et al. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study , 1998, BMJ.
[54] Oscar L. Lopez,et al. Risk Factors for Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.
[55] E Rostrup,et al. Cerebral Perfusion and Cerebrovascular Reactivity Are Reduced in White Matter Hyperintensities , 2002, Stroke.
[56] C B Hall,et al. Low blood pressure and the risk of dementia in very old individuals , 2003, Neurology.
[57] R Brookmeyer,et al. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.
[58] R. Mayeux,et al. Clinical determinants of dememtia related to stroke , 1993, Annals of neurology.
[59] E. O’Brien,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. , 1997, Lancet.
[60] Norman J Beauchamp,et al. White Matter Hyperintensity on Cranial Magnetic Resonance Imaging: A Predictor of Stroke , 2004, Stroke.
[61] L. Hansson. Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[62] B. Winblad,et al. The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.
[63] A Capdevila,et al. Leuko-araiosis on magnetic resonance imaging and speed of mental processing. , 1990, Archives of neurology.
[64] Charles DeCarli,et al. Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.
[65] D. Kildea,et al. Is senile dementia "age-related" or "ageing-related"? —evidence from meta-analysis of dementia prevalence in the oldest old , 1995, The Lancet.
[66] S. Marenco,et al. Regional Cerebral Blood Flow in Chronic Hypertension: A Correlative Study , 1993, Stroke.
[67] B. Lernfelt,et al. 15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.
[68] C. Dufouil,et al. Cognitive decline in individuals with high blood pressure , 1999, Neurology.
[69] R. Havlik,et al. Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.
[70] Sudha Seshadri,et al. Dementia After Stroke: The Framingham Study , 2004, Stroke.
[71] K. Wong,et al. Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[73] M. Woodward,et al. Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy , 2005, Circulation.
[74] M. Prince,et al. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults , 1996, BMJ.
[75] A. Hofman,et al. Cerebral white matter lesions and the risk of dementia. , 2004, Archives of neurology.
[76] B. Fagerberg,et al. Cognitive Impairment and Dementia 20 Months after Stroke , 2004, Neuroepidemiology.
[77] R. D'Agostino,et al. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. , 1993, American journal of epidemiology.
[78] L. Harrell,et al. The relationship of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer's disease. , 1991, Archives of neurology.
[79] C. Reynolds,et al. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. , 2001, The American journal of psychiatry.
[80] E Auffray,et al. Longitudinal study of blood pressure and white matter hyperintensities , 2001, Neurology.
[81] B. Winblad,et al. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. , 1999, Archives of neurology.
[82] J. Lodder,et al. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions , 1998, Movement disorders : official journal of the Movement Disorder Society.
[83] G. Román. From UBOs to Binswanger's disease. Impact of magnetic resonance imaging on vascular dementia research. , 1996, Stroke.
[84] J. V. van Swieten,et al. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. , 1991, Brain : a journal of neurology.
[85] V. Hachinski,et al. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). , 1987, Archives of neurology.
[86] R F Spetzler,et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. , 1986, Stroke.
[87] R. Mayeux,et al. Dementia after stroke , 1992, Neurology.
[88] R. Mayeux,et al. Risk of dementia after stroke in a hospitalized cohort , 1994, Neurology.
[89] I. Deary,et al. Brain white matter lesions detected by magnetic resosnance imaging are associated with balance and gait speed , 2003 .
[90] B Horwitz,et al. White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. , 1990, Archives of neurology.
[91] E. Kaplan,et al. Blood pressure and cognitive performance. The Framingham Study. , 1987, American journal of epidemiology.
[92] A. Elster,et al. Relationship between balance and abnormalities in cerebral magnetic resonance imaging in older adults. , 1998, Archives of neurology.
[93] James R. MacFall,et al. Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects , 2003, Biological Psychiatry.
[94] P. J. Koudstaal,et al. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe , 2005, Neurology.
[95] B. Winblad,et al. Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three-year follow-up. , 1998, Journal of clinical epidemiology.